Andrew P.

Senior Director - Process Development at Amgen

Cambridge, Massachusetts, United States

About

Head of Process Chemistry at Amgen. Experience with advancing accelerated oncology programs from IND through commercial launch, including all aspects of drug substance development (commercial process development, characterization, tech transfer, validation), authoring regulatory documents (IND and NDA/MAA, briefing books, RTQs), and participating in meetings with health authorities. Enjoys working in cross-functional CMC teams to enable advancement of high-impact and complex programs.

Experience

  • Amgen (13 yrs 2 mos)
    • Senior Director - Process Development
      Jul 2024 - Present · 2 yrs 1 mo

    • Director - Process Development
      Sep 2022 - Jul 2024 · 1 yr 11 mos

    • Principal Scientist - Process Development
      Dec 2020 - Sep 2022 · 1 yr 10 mos

  • Research Investigator II - Process Development at Bristol-Myers Squibb
    Mar 2012 - May 2013 · 1 yr 3 mos

  • Scientific Intern at The Scripps Research Institute
    Jun 2005 - Aug 2005 · 3 mos